Is Neurocrine Biosciences, Inc. technically bullish or bearish?

As of 24 October 2025, the technical trend for Neurocrine Biosciences, Inc. has changed from mildly bullish to bullish. The current stance is bullish with strong indicators supporting this view. The MACD is bullish on both weekly and monthly time frames, and Bollinger Bands also indicate a bullish trend in both time frames. Daily moving averages are bullish, while the On-Balance Volume (OBV) is bullish on both weekly and monthly scales. However, the KST shows a mildly bearish signal on both weekly and monthly, and Dow Theory indicates a mildly bearish stance on the weekly but a mildly bullish stance on the monthly.
In terms of performance, Neurocrine has outperformed the S&P 500 over the past week with a return of 2.79% compared to the S&P 500's 1.92%, but it has underperformed over the past month, year-to-date, and over the longer terms of 3, 5, and 10 years.